PT72066B - Process to prepare novel halophenyl-pyridil-allylamine derivatives and pharmaceutical compositions thereof - Google Patents

Process to prepare novel halophenyl-pyridil-allylamine derivatives and pharmaceutical compositions thereof

Info

Publication number
PT72066B
PT72066B PT72066A PT7206680A PT72066B PT 72066 B PT72066 B PT 72066B PT 72066 A PT72066 A PT 72066A PT 7206680 A PT7206680 A PT 7206680A PT 72066 B PT72066 B PT 72066B
Authority
PT
Portugal
Prior art keywords
pyridil
halophenyl
pharmaceutical compositions
prepare novel
allylamine derivatives
Prior art date
Application number
PT72066A
Other languages
English (en)
Other versions
PT72066A (en
Inventor
Thomas Hogberg
Thomas De Paulis
Svante Bertil Ross
Carl Bengt Johan Ulff
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of PT72066A publication Critical patent/PT72066A/pt
Publication of PT72066B publication Critical patent/PT72066B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/48—Aldehydo radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT72066A 1979-11-16 1980-11-14 Process to prepare novel halophenyl-pyridil-allylamine derivatives and pharmaceutical compositions thereof PT72066B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7909514A SE7909514L (sv) 1979-11-16 1979-11-16 Nya halofenyl-pyridyl-allylaminderivat

Publications (2)

Publication Number Publication Date
PT72066A PT72066A (en) 1980-12-01
PT72066B true PT72066B (en) 1982-09-02

Family

ID=20339337

Family Applications (1)

Application Number Title Priority Date Filing Date
PT72066A PT72066B (en) 1979-11-16 1980-11-14 Process to prepare novel halophenyl-pyridil-allylamine derivatives and pharmaceutical compositions thereof

Country Status (17)

Country Link
US (1) US4418065A (pt)
EP (2) EP0029420A1 (pt)
JP (1) JPS56501524A (pt)
AU (1) AU538087B2 (pt)
CA (1) CA1155128A (pt)
DK (1) DK300781A (pt)
ES (5) ES8204721A1 (pt)
FI (1) FI812196L (pt)
GR (1) GR72129B (pt)
NO (1) NO812401L (pt)
NZ (1) NZ195558A (pt)
PL (3) PL128457B1 (pt)
PT (1) PT72066B (pt)
SE (1) SE7909514L (pt)
SU (4) SU1103794A3 (pt)
WO (1) WO1981001407A1 (pt)
ZA (1) ZA807102B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1150269A (en) * 1980-11-14 1983-07-19 Carl B. J. Ulff Process for preparing 3-(4-bromophenyl)-3-(3-pyridyl)-allylamines
US4610995A (en) * 1984-07-27 1986-09-09 Coker Geoffrey G Certain 1,1-diaryl-propenyl-3-(1-pyrrolidino-2-carboxylic acids, derivatives thereof and their anti-histaminic properties
GB8814639D0 (en) * 1988-06-20 1988-07-27 Ici Plc Heterocyclic tertiary alcohol derivatives
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
GB0219154D0 (en) * 2002-08-16 2002-09-25 Pfizer Ltd Diaryl compounds
US6800652B2 (en) 2002-08-16 2004-10-05 Pfizer Inc. Diaryl compounds
SI3066091T1 (sl) 2013-11-05 2019-09-30 Astrazeneca Ab NMDA antagonist predzdravila

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2676964A (en) * 1950-06-07 1954-04-27 Schering Corp 3-pyridyl propylamine antihistamine substances
DE966534C (de) * 1951-03-22 1957-08-22 Schering Corp Verfahren zur Herstellung von basisch substituierten Pyridinverbindungen
GB850298A (en) 1956-10-30 1960-10-05 Maggioni & C Societa Per Azion ª‡,ª‡[(p-chlorophenyl)-(4-pyridyl)] carbinols and method of preparing same
DE1468359A1 (de) * 1963-10-23 1968-11-28 Merck & Co Inc Verfahren zur Herstellung von Dibenzocycloheptehderivaten
US3396224A (en) * 1965-09-09 1968-08-06 Lilly Co Eli Controlling phytopathogenic fungi on plants with 3-pyridyl methane derivatives
US3423510A (en) * 1966-08-31 1969-01-21 Geigy Chem Corp 3-(p-halophenyl) - 3 - (2'-pyridyl-n-methylpropylamine for the treatment of depression
US3471505A (en) * 1967-02-01 1969-10-07 Ciba Geigy Corp 1-(alkoxyphenyl)-1-(3-pyridyl)-carbinols
US3928369A (en) * 1971-04-28 1975-12-23 Haessle Ab Compounds useful as antidepressive agents, and a process for their preparation
US3928613A (en) * 1971-04-28 1975-12-23 Haessle Ab Compounds useful as antidepressive agents
SE361663B (pt) 1971-04-28 1973-11-12 Haessle Ab
SE373850B (pt) 1972-11-16 1975-02-17 Haessle Ab
US4094908A (en) * 1973-08-15 1978-06-13 Richter Gedeon Vegyeszeti Gyar Rt. Alpha-substituted benzhydrol derivatives
GB1480593A (en) * 1973-11-30 1977-07-20 Kefalas As Xanthene and thioxanthene derivatives having pharmaceutical activity
US4186202A (en) * 1974-11-21 1980-01-29 Astra Lakemedel Aktiebolag Phenyl-pyridylamine derivatives
US4102887A (en) * 1974-11-21 1978-07-25 Per Arvid Emil Carlsson Intermediates used in the preparation of phenyl-pyridylamine derivatives
SE388854B (sv) 1974-11-21 1979-03-26 Astra Laekemedel Ab Forfarande for framstellning av fenylpyridylaminderivat
SE418291B (sv) * 1976-05-17 1981-05-18 Astra Laekemedel Ab 4-bromfenyl-3-pyridylderivat som mellanprodukter vid framstellning av fenylpyridylaminer
SE418399B (sv) * 1976-05-21 1981-05-25 Astra Laekemedel Ab Forfarande for framstellning av n,n-dimetyl-3-(4 bromfenyl)-3-(3-pyridyl)allylamin
SE409706B (sv) 1976-05-21 1979-09-03 Astra Pharma Prod Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat
SE409860B (sv) 1977-07-04 1979-09-10 Astra Laekemedel Ab En ny mellanprodukt for framstellning av terapeutiskt aktiva pyridinforeningar
IE47628B1 (en) * 1977-07-04 1984-05-16 Astra Laekemedel Ab Substituted aralkyl amines and amino-aryl alkenes having therapeutic activity
SE409861B (sv) * 1977-07-04 1979-09-10 Astra Laekemedel Ab Ett nytt forfarande for framstellning av en terapeutisk aktiv pyridinforening

Also Published As

Publication number Publication date
JPS56501524A (pt) 1981-10-22
ES8300096A1 (es) 1982-10-01
CA1155128A (en) 1983-10-11
NO812401L (no) 1981-07-13
SU1149874A3 (en) 1985-04-07
SU1149875A3 (ru) 1985-04-07
ES8300097A1 (es) 1982-10-01
NZ195558A (en) 1984-07-06
ES496859A0 (es) 1982-05-01
SU1103794A3 (ru) 1984-07-15
ES508065A0 (es) 1982-10-01
ES8300094A1 (es) 1982-10-01
PL227849A1 (pt) 1981-12-23
PL128457B1 (en) 1984-01-31
EP0081478A3 (en) 1984-01-04
GR72129B (pt) 1983-09-16
ES8300095A1 (es) 1982-10-01
ES508062A0 (es) 1982-10-01
SE7909514L (sv) 1981-05-17
FI812196L (fi) 1981-07-10
AU6437880A (en) 1981-05-21
PL232732A1 (pt) 1982-08-16
PT72066A (en) 1980-12-01
ES508064A0 (es) 1982-10-01
WO1981001407A1 (en) 1981-05-28
US4418065A (en) 1983-11-29
EP0081478A2 (en) 1983-06-15
DK300781A (da) 1981-07-07
ZA807102B (en) 1981-07-29
PL129369B1 (en) 1984-05-31
PL232731A1 (pt) 1982-08-16
EP0029420A1 (en) 1981-05-27
PL129370B1 (en) 1984-05-31
SU1138021A3 (ru) 1985-01-30
ES8204721A1 (es) 1982-05-01
ES508063A0 (es) 1982-10-01
AU538087B2 (en) 1984-07-26

Similar Documents

Publication Publication Date Title
GB2103591B (en) Pharmaceutical compositions and process
DE2961979D1 (en) Novel naphtyridine derivatives and pharmaceutical compositions containing them
JPS5392752A (en) Novel 11betaasubstituted 4*99dienesteroid derivative process for preparing same and pharmaceutical composition
IL58079A0 (en) Fabrinolytic enzyme derivatives their preparation and pharmaceutical compositions containing them
MY8700186A (en) 3-aminopropoxyaryl derivatives their preparation and pharmaceutical compositions containing them
NZ193798A (en) 3-thiovinyl-cephalosporin derivatives and pharmaceutical compositions
IL56407A (en) 4-amino-3-sulfamoylpyridyl derivatives and pharmaceutical compositions containing them
JPS5390254A (en) Novel 11betaasubstituted 1*3*5*10**trienesteroid process for preparing same and pharmaceutical composition
DE2964209D1 (en) Spiro-furanohydantoin derivatives, process for their preparation and pharmaceutical compositions containing them
JPS53103500A (en) Novel 20*211dinoreblmnamenine derivative process for preparing same and pharmaceutical composition
IL57268A0 (en) Di-o-n-alkyl clycerol derivatives and pharmaceutical compositions containing them
PT72066B (en) Process to prepare novel halophenyl-pyridil-allylamine derivatives and pharmaceutical compositions thereof
NZ194784A (en) 7 -aminothiadizolylacetylamino-3-cephem-4-carboxylic acid derivatives and pharmaceutical compositions
PT71411A (en) Process for preparing novel quinazoline derivatives and pharmaceutical compositions thereof
GB2044756B (en) Fluoro-amines processes for their preparation and pharmaceutical compositions containing them
GB2032423B (en) N - phenyl-indoline derivatives their production and pharmaceutical compositions containing them
GB2038802B (en) Aryltrifluoroethanols process for their preparation and pharmaceutical compositions containing them
GB2053914B (en) Sulphur-containing isoquinoline derivatives process for thereof and pharmaceutical compositions containing them
PH16220A (en) Pyrro-lidine derivatives and pharmaceutical compositions thereof
NZ189769A (en) Benzylidene derivatives and pharmaceutical compositions
IL58438A0 (en) Isoquinoline derivatives their preparation and pharmaceutical compositions containing them
NZ194122A (en) Acylaminobenzoic acid derivatives and pharmaceutical compositions
NZ190665A (en) S-benzylcysteine derivatives and pharmaceutical compositions
NZ190007A (en) Steroid-spiro-oxazolidinone derivatives and pharmaceutical compositions
GR63662B (en) Piperazinecarbodithioic acid derivatives process for their preparation and pharmaceutical compositions containing them